Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy
The study demonstrates that hypermetabolic CTC could enhance risk stratification in orHSPC patients undergoing SBRT, particularly in patients with limited metastatic burden, potentially identifying patients with indolent disease who are suitable for tailored SBRT interventions.
Authors
- Agostino Steffan (ORCID: https://orcid.org/0000-0002-6320-3054)
- Giulia Brisotto (ORCID: https://orcid.org/0000-0001-5514-7032)
- Lucia Fratino (ORCID: https://orcid.org/0000-0002-5550-0868)
- Alessandra Donofrio (ORCID: https://orcid.org/0000-0001-7576-2462)
- Elena Muraro (ORCID: https://orcid.org/0000-0001-9514-8224)
- Martina Zanchetta (ORCID: https://orcid.org/0000-0002-5018-7032)
- Roberto Bortolus (ORCID: https://orcid.org/0000-0002-1268-4425)
- Marcella Montico (ORCID: https://orcid.org/0000-0003-0377-8232)
- Matteo Turetta (ORCID: https://orcid.org/0000-0001-6446-6764)
- Fabio Matrone (ORCID: https://orcid.org/0000-0002-2292-0444)
- Fabio Del Ben (ORCID: https://orcid.org/0000-0002-1880-0669)
- Veronica Paduano
Institutions
- Centro di Riferimento Oncologico (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- The Prostate
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1002/pros.24787
- Citations
- 4
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Ministero della Salute